CERT logo

Certara Inc. (CERT)

$5.34

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CERT

Market cap

$830715007

EPS

-0.1

P/E ratio

--

Price to sales

2.24

Dividend yield

--

Beta

1.494969

Price on CERT

Previous close

$5.54

Today's open

$5.48

Day's range

$5.31 - $5.79

52 week range

$4.45 - $13.88

Profile about CERT

CEO

Jon Resnick

Employees

1546

Headquarters

Radnor, PA

Exchange

Nasdaq Global Select

Shares outstanding

155564608

Issue type

Common Stock

CERT industries and sectors

Healthcare

Healthcare Providers & Services

News on CERT

Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. on Behalf of Certara Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Certara (CERT) To Contact Him Directly To Discuss Their Options

news source

GlobeNewsWire • Jun 19, 2026

news preview

Certara, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Certara, Inc. (NASDAQ: CERT). The investigation focuses on Certara's executive officers and whether investor losses may be recovered under federal securities laws.

news source

GlobeNewsWire • Jun 18, 2026

news preview

Certara Announces CFO Transition

RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified the Company of his intent to resign from his office effective as of the end of the day on July 14, 2026.

news source

GlobeNewsWire • Jun 17, 2026

news preview

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc. - CERT

NEW YORK, June 11, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Certara, Inc. ("Certara" or the "Company") (NASDAQ: CERT).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

news source

PRNewsWire • Jun 11, 2026

news preview

CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm

LOS ANGELES, June 11, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Certara, Inc. ("Certara" or "the Company") (NASDAQ: CERT) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

news source

PRNewsWire • Jun 11, 2026

news preview

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference

Certara NASDAQ: CERT executives outlined the company's strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies' 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creating clearer growth engines and improving execution.

news source

MarketBeat • Jun 7, 2026

news preview

Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Certara, Inc. (CERT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Jun 3, 2026

news preview

Cerrado Gold Inc. (CERT:CA) Q1 2026 Earnings Call Transcript

Cerrado Gold Inc. (CERT:CA) Q1 2026 Earnings Call Transcript

news source

Seeking Alpha • May 29, 2026

news preview

CERT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Certara, Inc. (“Certara” or the “Company”) (NASDAQ:CERT) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.

news source

GlobeNewsWire • May 22, 2026

news preview

Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Certara, Inc. (CERT) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • May 19, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Certara Inc.

Open an M1 investment account to buy and sell Certara Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CERT on M1